Big News
Figure 1. Average percentage increase in cell survival relative to amyloid treated control cells. Zero is the benchmark for AB effected cells with no treatments, whereby cell viability was 65.5%. Cell viability increased by 2.1% to 67.6% for Donepezil, by 11.6% to 77.1% for CBD and by 20.1% to 85.6% for AI-116. These results demonstrate that the combination of CBD and Donepezil synergise to increase the neuroprotective effect in neuronal cells that are exposed to toxic Amyloid β, with the observed combined effect of the two drugs on cell viability is 33% greater than what would be expected if we added together the effects of each drug used alone.
- Forums
- ASX - By Stock
- 1AI
- Ann: Positive results from AI-116 in vitro studies
Ann: Positive results from AI-116 in vitro studies, page-2
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 4863067 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 950168 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 4863067 | 0.006 |
10 | 3971842 | 0.005 |
6 | 3695009 | 0.004 |
2 | 3100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 950168 | 3 |
0.008 | 2252112 | 10 |
0.009 | 2028673 | 10 |
0.010 | 2788587 | 5 |
0.011 | 208125 | 2 |
Last trade - 16.12pm 18/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
Day chart unavailable